In Health Care You Don’t Become A Unicorn Overnight
Medtech Investor Tells Start-Ups To Not Be Exclusively Bound Up By The Coronavirus Crisis
Executive Summary
The pandemic has shaken up investor priorities and changed the outlook for health care start-ups – or has it? Nooman Haque managing director, life sciences and healthcare at Silicon Valley Bank, gives his view of what has changed over the past year, and looks at future trends.
You may also be interested in...
VC View: Riding The Waves Of Asia’s Healthtech Explosion
Asia continues to gain attention for its healthtech innovation and adoption activity, and VC investors have seen the merits of a maintaining a focus on this newly emerging regional innovation hotspot, regardless of the pandemic.
South Korea Roundup: Augmented Reality Device Guidelines, Digital, UDI And IVD Updates
The devices regulator has sought private sector input in updating AR/VR guidelines, but needs to do more on telemedicine integration. Mixed experiences are reported on UDI and the new IVD regulation.
Interview: Royal Philips’ Journey From Medtech Supplier To Healthtech Partner
Health care delivery has been transformed over the past decade, and so has Royal Philips, whose CEO Frans van Houten explains why both were necessary, and the extra impetus for system-wide change following the COVID-19 pandemic.